Full Text View
Tabular View
Study Results
Related Studies
Lume Lung 2 : Nintedanib Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC
This study is ongoing, but not recruiting participants.
Study NCT00806819   Information provided by Boehringer Ingelheim

First Received on December 10, 2008.   Last Updated on November 14, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial